genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Agilent
Bioprocessing
Agilent to Acquire Biovectra for $925M, Expanding CDMO Portfolio
Artificial Intelligence
Laboratory Automation Reaches Every Stage of Drug Development
News
Illumina to Divest of Grail after Appeals Court Defeat
GEN Edge
StockWatch: Investors, Analysts Debate Background of New Illumina CEO
Industry News
Illumina’s New CEO: Board Appoints Agilent’s Jacob Thaysen
Genome Editing
The Long and Winding Road: On-Demand DNA Synthesis in High Demand
Bioprocessing
Real Time Bioprocessing
Insights
Raise the Analytical Bar When Turning Oligos into Therapeutics
Bioprocessing
Agilent Investing $725 Million to Expand Manufacturing Capacity for Nucleic Acid-Based Therapeutic Production
Sponsored
Evaluating CAR T Cells: In Vitro Potency Assays for Production, Quality Control, Efficacy, and Safety
1
2
3
...
11
Page 1 of 11
Scroll Up
Scroll Up
